DBV Technologies sells $30 million of shares through ATM program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St futures rebound as oil retreats, investors weigh US-Iran tensions
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025 5:02 PM EDTChâtillon, France, October 6, 2025
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies (Euronext: DBV ISIN: FR0010417345 Nasdaq Capital Market: DBVT) (the Company), a clinical-stage biopharmaceutical company, today announced that, pursuant to the Companys At-The-Market program established on September 5, 2025 (the ATM Program), it has agreed to issue and sell new ordinary shares (the Ordinary Shares) in the form of American Depositary Shares (ADSs), for total gross proceeds to the Company of approximately $30 million, before deducting sales agent commissions... More
